Insulin resistance as a therapeutic target in the treatment of Alzheimer's disease: A state-of-the-art review

Frontiers in Neuroscience

Volumn 12, Issue APR, 2018, Pages

  Benedict, Christian ^a   Grillo, Claudia A ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid beta; Diabetes; Intranasal insulin; Mild cognitive impairment; Neurofibrillary tangles

Indexed keywords

AMYLOID BETA PROTEIN; INSULIN; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; HUMAN; INSULIN RESISTANCE; INSULIN SIGNALING; MILD COGNITIVE IMPAIRMENT; NONHUMAN; PATHOGENESIS; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 85045275079     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2018.00215     Document Type: Review

References (136)

1. Ahtiluoto, S., Polvikoski, T., Peltonen, M., Solomon, A., Tuomilehto, J., Winblad, B., et al. (2010). Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75, 1195-1202. doi: 10.1212/WNL.0b013e3181f4d7f8
2. Baker, L. D., Cross, D. J., Minoshima, S., Belongia, D., Watson, G. S., and Craft, S. (2011). Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch. Neurol. 68, 51-57. doi: 10.1001/archneurol.2010.225
3. Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., et al. (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis. Assoc. Disord. 16, 203-212. doi: 10.1097/00002093-200210000-00001
4. Becker, K., Freude, S., Zemva, J., Stöhr, O., Krone, W., and Schubert, M. (2012). Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo. Neurosci. Lett. 516, 306-310. doi: 10.1016/j.neulet.2012.04.022
5. Benedict, C., Brede, S., Schiöth, H. B., Lehnert, H., Schultes, B., Born, J., et al. (2011). Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes 60, 114-118. doi: 10.2337/db10-0329
6. Benedict, C., Brooks, S. J., Kullberg, J., Burgos, J., Kempton, M. J., Nordenskjöld, R., et al. (2012). Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 35, 488-494. doi: 10.2337/dc11-2075
7. Benedict, C., Hallschmid, M., Hatke, A., Schultes, B., Fehm, H. L., Born, J., et al. (2004). Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29, 1326-1334. doi: 10.1016/j.psyneuen.2004.04.003
8. Benedict, C., Hallschmid, M., Schmitz, K., Schultes, B., Ratter, F., Fehm, H. L., et al. (2007). Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32, 239-243. doi: 10.1038/sj.npp.1301193
9. Benedict, C., Kern, W., Schultes, B., Born, J., and Hallschmid, M. (2008). Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 93, 1339-1344. doi: 10.1210/jc.2007-2606
10. Biessels, G. J., and Reagan, L. P. (2015). Hippocampal insulin resistance and cognitive dysfunction. Nat. Rev. Neurosci. 16, 660-671. doi: 10.1038/nrn4019
11. Biessels, G. J., and Reijmer, Y. D. (2014). Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 63, 2244-2252. doi: 10.2337/db14-0348
12. Bohringer, A., Schwabe, L., Richter, S., and Schachinger, H. (2008). Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress. Psychoneuroendocrinology 33, 1394-1400. doi: 10.1016/j.psyneuen.2008.08.002
13. Bomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J.-C., Decker, H., et al. (2012). An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers. J. Clin. Invest. 122, 1339-1353. doi: 10.1172/JCI57256
14. Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., et al. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 343, 450-456. doi: 10.1056/NEJM200008173430701
15. Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., and Fehm, H. L. (2002). Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5, 514-516. doi: 10.1038/nn849
16. Brief, D. J., and Davis, J. D. (1984). Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Res. Bull. 12, 571-575
17. Bruehl, H., Sweat, V., Hassenstab, J., Polyakov, V., and Convit, A. (2010). Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J. Clin. Exp. Neuropsychol. 32, 487-493. doi: 10.1080/13803390903224928
18. Brünner, Y. F., Kofoet, A., Benedict, C., and Freiherr, J. (2015). Central insulin administration improves odor-cued reactivation of spatial memory in young men. J. Clin. Endocrinol. Metab. 100, 212-219. doi: 10.1210/jc.2014-3018
19. Calsolaro, V., and Edison, P. (2015). Novel GLP-1 (glucagon-like peptide-1) analogues and insulin in the treatment for Alzheimer's disease and other neurodegenerative diseases. CNS Drugs 29, 1023-1039. doi: 10.1007/s40263-015-0301-8
20. Cedernaes, J., Osorio, R. S., Varga, A. W., Kam, K., Schiöth, H. B., and Benedict, C. (2017). Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease. Sleep Med. Rev. 31, 102-111. doi: 10.1016/j.smrv.2016.02.002
21. Cedernaes, J., Sand, F., Liethof, L., Lampola, L., Hassanzadeh, S., Axelsson, E. K., et al. (2016). Learning and sleep-dependent consolidation of spatial and procedural memories are unaltered in young men under a fixed short sleep schedule. Neurobiol. Learn. Mem. 131, 87-94. doi: 10.1016/j.nlm.2016.03.012
22. Chao, A.-C., Lee, T.-C., Juo, S.-H. H., and Yang, D.-I. (2016). Hyperglycemia increases the production of amyloid beta-peptide leading to decreased endothelial tight junction. CNS Neurosci. Ther. 22, 291-297. doi: 10.1111/cns.12503
23. Chapman, C. D., Frey, W. H., Craft, S., Danielyan, L., Hallschmid, M., Schiöth, H. B., et al. (2013). Intranasal treatment of central nervous system dysfunction in humans. Pharm. Res. 30, 2475-2484. doi: 10.1007/s11095-012-0915-1
24. Chua, L.-M., Lim, M.-L., Chong, P.-R., Hu, Z. P., Cheung, N. S., and Wong, B.-S. (2012). Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1E9 mice. J. Alzheimers Dis. 29, 783-791. doi: 10.3233/JAD-2012-111880
25. Claxton, A., Baker, L. D., Hanson, A., Trittschuh, E. H., Cholerton, B., Morgan, A., et al. (2015). Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J. Alzheimers Dis. 44, 897-906. doi: 10.3233/JAD-141791
26. Claxton, A., Baker, L. D., Wilkinson, C. W., Trittschuh, E. H., Chapman, D., Watson, G. S., et al. (2013). Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J. Alzheimers. Dis. 35, 789-797. doi: 10.3233/JAD-122308
27. Convit, A., Wolf, O. T., Tarshish, C., and de Leon, M. J. (2003). Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl. Acad. Sci. U.S.A. 100, 2019-2022. doi: 10.1073/pnas.0336073100
28. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923
29. Craft, S., Baker, L. D., Montine, T. J., Minoshima, S., Watson, G. S., Claxton, A., et al. (2012). Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment. Arch. Neurol. 69:29. doi: 10.1001/archneurol.2011.233
30. Craft, S., Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., et al. (2017). Effects of regular and long-acting insulin on cognition and Alzheimer's disease biomarkers: a pilot clinical trial. J. Alzheimers Dis. 57, 1325-1334. doi: 10.3233/JAD-161256
31. Crane, P. K., Walker, R. L., Sonnen, J., Gibbons, L. E., Melrose, R., Hassenstab, J., et al. (2016). Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes. Neurobiol. Aging 48, 72-82. doi: 10.1016/j.neurobiolaging.2016.07.021
32. Crane, P. K., Walker, R., Hubbard, R. A., Li, G., Nathan, D. M., Zheng, H., et al. (2013). Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540-548. doi: 10.1056/NEJMoa1215740
33. Cukierman, T., Gerstein, H. C., and Williamson, J. D. (2005). Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48, 2460-2469. doi: 10.1007/s00125-005-0023-4
34. Dankner, R., Chetrit, A., Shanik, M. H., Raz, I., and Roth, J. (2009). Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 32, 1464-1466. doi: 10.2337/dc09-0153
35. De Felice, F. G., and Ferreira, S. T. (2014). Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63, 2262-2272. doi: 10.2337/db13-1954
36. De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., et al. (2009). Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl. Acad. Sci. U.S.A. 106, 1971-1976. doi: 10.1073/pnas.0809158106
37. de la Monte, S. M. (2012). Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr. Alzheimer Res. 9, 35-66. doi: 10.2174/156720512799015037
38. Diekelmann, S., and Born, J. (2010). The memory function of sleep. Nat. Rev. Neurosci. 11, 114-126. doi: 10.1038/nrn2762
39. Ekblad, L. L., Rinne, J. O., Puukka, P., Laine, H., Ahtiluoto, S., Sulkava, R., et al. (2017). Insulin resistance predicts cognitive decline: an 11-year follow-up of a nationally representative adult population sample. Diabetes Care 40, 751-758. doi: 10.2337/dc16-2001
40. El Khoury, N. B., Gratuze, M., Papon, M.-A., Bretteville, A., and Planel, E. (2014). Insulin dysfunction and Tau pathology. Front. Cell. Neurosci. 8:22. doi: 10.3389/fncel.2014.00022
41. Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., et al. (2006). Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129, 2856-2866. doi: 10.1093/brain/awl178
42. Feld, G. B., Wilhem, I., Benedict, C., Rüdel, B., Klameth, C., Born, J., et al. (2016). Central nervous insulin signaling in sleep-associated memory formation and neuroendocrine regulation. Neuropsychopharmacology 41, 1540-1550. doi: 10.1038/npp.2015.312
43. Fernandez, A. M., and Torres-Alemán, I. (2012). The many faces of insulin-like peptide signalling in the brain. Nat. Rev. Neurosci. 13, 225-239. doi: 10.1038/nrn3209
44. Fishel, M. A., Watson, G. S., Montine, T. J., Wang, Q., Green, P. S., Kulstad, J. J., et al. (2005). Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults. Arch. Neurol. 62, 1539-1544. doi: 10.1001/archneur.62.10.noc50112
45. Freiherr, J., Hallschmid, M., Frey, W. H., Brünner, Y. F., Chapman, C. D., Hölscher, C., et al. (2013). Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. CNS Drugs 27, 505-514. doi: 10.1007/s40263-013-0076-8
46. Freude, S., Hettich, M. M., Schumann, C., Stohr, O., Koch, L., Kohler, C., et al. (2009). Neuronal IGF-1 resistance reduces A accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J. 23, 3315-3324. doi: 10.1096/fj.09-132043
47. Freude, S., Plum, L., Schnitker, J., Leeser, U., Udelhoven, M., Krone, W., et al. (2005). Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. Diabetes 54, 3343-3348. doi: 10.2337/diabetes.54.12.3343
48. Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., et al. (1998). Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm. 105:423. doi: 10.1007/s007020050068
49. Frölich, L., Blum-Degen, D., Riederer, P., and Hoyer, S. (1999). A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann. N. Y. Acad. Sci. 893, 290-293
50. Frosch, O. H., Yau, P. L., Osorio, R. S., Rusinek, H., Storey, P., and Convit, A. (2017). Insulin resistance among obese middle-aged is associated with decreased cerebrovascular reactivity. Neurology 89, 249-255. doi: 10.1212/WNL.0000000000004110
51. Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., et al. (2016). In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial. Front. Aging Neurosci. 8:108. doi: 10.3389/fnagi.2016.00108
52. Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., and Klug, A. (1988). Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U.S.A. 85, 4051-4055
53. Golde, T. E., Eckman, C. B., and Younkin, S. G. (2000). Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim. Biophys. Acta 1502, 172-187. doi: 10.1016/S0925-4439(00)00043-0
54. Griffin, R. J., Moloney, A., Kelliher, M., Johnston, J. A., Ravid, R., Dockery, P., et al. (2005). Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 93, 105-117. doi: 10.1111/j.1471-4159.2004.02949.x
55. Grillo, C. A., Piroli, G. G., Lawrence, R. C., Wrighten, S. A., Green, A. J., Wilson, S. P., et al. (2015). Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes 64, 3927-3936. doi: 10.2337/db15-0596
56. Grillo, C. A., Tamashiro, K. L., Piroli, G. G., Melhorn, S., Gass, J. T., Newsom, R. J., et al. (2007). Lentivirus-mediated downregulation of hypothalamic insulin receptor expression. Physiol. Behav. 92, 691-701. doi: 10.1016/j.physbeh.2007.05.043
57. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83, 4913-4917
58. Haj-ali, V., Mohaddes, G., and Babri, S. H. (2009). Intracerebroventricular insulin improves spatial learning and memory in male Wistar rats. Behav. Neurosci. 123, 1309-1314. doi: 10.1037/a0017722
59. Hallschmid, M., Benedict, C., Schultes, B., Born, J., and Kern, W. (2008). Obese men respond to cognitive but not to catabolic brain insulin signaling. Int. J. Obes. 32, 275-282. doi: 10.1038/sj.ijo.0803722
60. Hallschmid, M., Benedict, C., Schultes, B., Fehm, H.-L., Born, J., and Kern, W. (2004). Intranasal insulin reduces body fat in men but not in women. Diabetes 53, 3024-3029. doi: 10.2337/diabetes.53.11.3024
61. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
62. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., et al. (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333-336. doi: 10.1038/nature01137
63. Holtzman, D. M., Mandelkow, E., and Selkoe, D. J. (2012). Alzheimer Disease in 2020. Cold Spring Harb. Perspect. Med. 2:a011585. doi: 10.1101/cshperspect.a011585
64. Hoscheidt, S. M., Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., et al. (2016). Insulin resistance is associated with increased levels of cerebrospinal fluid biomarkers of Alzheimer's disease and reduced memory function in at-risk healthy middle-aged adults. J. Alzheimers Dis. 52, 1373-1383. doi: 10.3233/JAD-160110
65. Jack, C. R., and Holtzman, D. M. (2013). Biomarker modeling of Alzheimer's disease. Neuron 80, 1347-1358. doi: 10.1016/j.neuron.2013.12.003
66. Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., et al. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207-216. doi: 10.1016/S1474-4422(12)70291-0
67. Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. doi: 10.1016/S1474-4422(09)70299-6
68. Jiang, Q., Zhang, L., Ding, G., Davoodi-Bojd, E., Li, Q., Li, L., et al. (2017). Impairment of the glymphatic system after diabetes. J. Cereb. Blood Flow Metab. 37, 1326-1337. doi: 10.1177/0271678X16654702
69. Johnson, S. C., Christian, B. T., Okonkwo, O. C., Oh, J. M., Harding, S., Xu, G., et al. (2014). Amyloid burden and neural function in people at risk for Alzheimer's disease. Neurobiol. Aging 35, 576-584. doi: 10.1016/j.neurobiolaging.2013.09.028
70. Kamal, A., Ramakers, G. M. J., Gispen, W. H., Biessels, G. J., and Al Ansari, A. (2013). Hyperinsulinemia in rats causes impairment of spatial memory and learning with defects in hippocampal synaptic plasticity by involvement of postsynaptic mechanisms. Exp. Brain Res. 226, 45-51. doi: 10.1007/s00221-013-3409-4
71. Kim, J., Basak, J. M., and Holtzman, D. M. (2009). The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303. doi: 10.1016/j.neuron.2009.06.026
72. Koenig, A. M., Mechanic-Hamilton, D., Xie, S. X., Combs, M. F., Cappola, A. R., Xie, L., et al. (2017). Effects of the insulin sensitizer metformin in alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis. Assoc. Disord. 31, 107-113. doi: 10.1097/WAD.0000000000000202
73. Kupila, A., Sipilä, J., Keskinen, P., Simell, T., Knip, M., Pulkki, K., et al. (2003). Intranasally administered insulin intended for prevention of type 1 diabetes-a safety study in healthy adults. Diabetes. Metab. Res. Rev. 19, 415-420. doi: 10.1002/dmrr.397
74. Last, D., Alsop, D. C., Abduljalil, A. M., Marquis, R. P., de Bazelaire, C., Hu, K., et al. (2007). Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 30, 1193-1199. doi: 10.2337/dc06-2052
75. Li, X. L., Aou, S., Hori, T., and Oomura, Y. (2002). Spatial memory deficit and emotional abnormality in OLETF rats. Physiol. Behav. 75, 15-23. doi: 10.1016/S0031-9384(01)00627-8
76. Liu, Y., Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C.-X. (2011). Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J. Pathol. 225, 54-62. doi: 10.1002/path.2912
77. Liu, Y., Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C.-X. (2009). Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. J. Neurochem. 111, 242-249. doi: 10.1111/j.1471-4159.2009.06320.x
78. Lochhead, J. J., Wolak, D. J., Pizzo, M. E., and Thorne, R. G. (2015). Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J. Cereb. Blood Flow Metab. 35, 371-381. doi: 10.1038/jcbfm.2014.215
79. Lockie, S. H. (2013). Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity. J. Neuroendocrinol. 25, 597-604. doi: 10.1111/jne.12039
80. Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., et al. (2016). Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial. J. Alzheimers. Dis. 51, 501-514. doi: 10.3233/JAD-150493
81. MacAuley, S. L., Stanley, M., Caesar, E. E., Yamada, S. A., Raichle, M. E., Perez, R., et al. (2015). Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo. J. Clin. Invest. 125, 2463-2467. doi: 10.1172/JCI79742
82. MacKlin, L., Griffith, C. M., Cai, Y., Rose, G. M., Yan, X.-X., and Patrylo, P. R. (2017). Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline. Exp. Gerontol. 88, 9-18. doi: 10.1016/j.exger.2016.12.019
83. Maj, M., Hoermann, G., Rasul, S., Base, W., Wagner, L., and Attems, J. (2016). The microtubule-associated protein tau and its relevance for pancreatic beta cells. J. Diabetes Res. 2016:1964634. doi: 10.1155/2016/1964634
84. Mandelkow, E.-M., Thies, E., Trinczek, B., Biernat, J., and Mandelkow, E. (2004). MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J. Cell Biol. 167, 99-110. doi: 10.1083/jcb.200401085
85. Marciniak, E., Leboucher, A., Caron, E., Ahmed, T., Tailleux, A., Dumont, J., et al. (2017). Tau deletion promotes brain insulin resistance. J. Exp. Med. 214, 2257-2269. doi: 10.1084/jem.20161731
86. McClean, P. L., and Hölscher, C. (2014). Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease. Neuropharmacology 76, 57-67. doi: 10.1016/j.neuropharm.2013.08.005
87. McClean, P. L., Gault, V. A., Harriott, P., and Hölscher, C. (2010). Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur. J. Pharmacol. 630, 158-162. doi: 10.1016/j.ejphar.2009.12.023
88. McClean, P. L., Parthsarathy, V., Faivre, E., and Holscher, C. (2011). The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J. Neurosci. 31, 6587-6594. doi: 10.1523/JNEUROSCI.0529-11.2011
89. McNay, E. C., Ong, C. T., McCrimmon, R. J., Cresswell, J., Bogan, J. S., and Sherwin, R. S. (2010). Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol. Learn. Mem. 93, 546-553. doi: 10.1016/j.nlm.2010.02.002
90. Moloney, A. M., Griffin, R. J., Timmons, S., O'Connor, R., Ravid, R., and O'Neill, C. (2010). Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 31, 224-243. doi: 10.1016/j.neurobiolaging.2008.04.002
91. Moosavi, M., Naghdi, N., and Choopani, S. (2007). Intra CA1 insulin microinjection improves memory consolidation and retrieval. Peptides 28, 1029-1034. doi: 10.1016/j.peptides.2007.02.010
92. Morris, J. K., Vidoni, E. D., Honea, R. A., and Burns, J. M., and Alzheimer's Disease Neuroimaging Initiative (2014). Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol. Aging 35, 585-589. doi: 10.1016/j.neurobiolaging.2013.09.033
93. Mullins, R. J., Mustapic, M., Goetzl, E. J., and Kapogiannis, D. (2017). Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease. Hum. Brain Mapp. 38, 1933-1940. doi: 10.1002/hbm.23494
94. Nelson, P. T., Smith, C. D., Abner, E. A., Schmitt, F. A., Scheff, S. W., Davis, G. J., et al. (2009). Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim. Biophys. Acta 1792, 454-469. doi: 10.1016/j.bbadis.2008.08.005
95. Nisticò, R., Cavallucci, V., Piccinin, S., Macrì, S., Pignatelli, M., Mehdawy, B., et al. (2012). Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase, LTP, and recognition memory. Neuromol. Med. 14, 262-269. doi: 10.1007/s12017-012-8184-z
96. Novak, V., Milberg, W., Hao, Y., Munshi, M., Novak, P., Galica, A., et al. (2014). Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care 37, 751-759. doi: 10.2337/dc13-1672
97. Park, C. R., Seeley, R. J., Craft, S., and Woods, S. C. (2000). Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol. Behav. 68, 509-514. doi: 10.1016/S0031-9384(99)00220-6
98. Pearson-Leary, J., and McNay, E. C. (2012). Intrahippocampal administration of amyloid-β(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism. J. Alzheimers Dis. 30, 413-422. doi: 10.3233/JAD-2012-112192
99. Pei, J.-J., Khatoon, S., An, W.-L., Nordlinder, M., Tanaka, T., Braak, H., et al. (2003). Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol. 105, 381-392. doi: 10.1007/s00401-002-0657-y
100. Peila, R., Rodriguez, B. L., White, L. R., and Launer, L. J. (2004). Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 63, 228-233. doi: 10.1212/01.WNL.0000129989.28404.9B
101. Perrin, R. J., Fagan, A. M., and Holtzman, D. M. (2009). Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916-922. doi: 10.1038/nature08538
102. Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., et al. (1998). Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273, 32730-32738
103. Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., et al. (2006). Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 27, 451-458. doi: 10.1016/j.neurobiolaging.2005.03.016
104. Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., et al. (2008a). Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J. Alzheimers Dis. 13, 323-331. doi: 10.3233/JAD-2008-13309
105. Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., et al. (2008b). Intranasal insulin improves cognition and modulates-amyloid in early AD. Neurology 70, 440-448. doi: 10.1212/01.WNL.0000265401.62434.36
106. Roberts, R. O., Knopman, D. S., Cha, R. H., Mielke, M. M., Pankratz, V. S., Boeve, B. F., et al. (2014). Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J. Nucl. Med. 55, 759-764. doi: 10.2967/jnumed.113.132647
107. Sajan, M., Hansen, B., Ivey, R., Sajan, J., Ari, C., Song, S., et al. (2016). Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1a and increases in Aβ1-40/42 and phospho-tau may Abet Alzheimer development. Diabetes 65, 1892-1903. doi: 10.2337/db15-1428
108. Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., et al. (2004). Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 101, 3100-3105. doi: 10.1073/pnas.0308724101
109. Shiiki, T., Ohtsuki, S., Kurihara, A., Naganuma, H., Nishimura, K., Tachikawa, M., et al. (2004). Brain insulin impairs amyloid-(1-40) clearance from the brain. J. Neurosci. 24, 9632-9637. doi: 10.1523/JNEUROSCI.2236-04.2004
110. Sims-Robinson, C., Kim, B., Rosko, A., and Feldman, E. L. (2010). How does diabetes accelerate Alzheimer disease pathology? Nat. Rev. Neurol. 6, 551-559. doi: 10.1038/nrneurol.2010.130
111. Small, S. A., and Duff, K. (2008). Linking Aβ and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60, 534-542. doi: 10.1016/j.neuron.2008.11.007
112. Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., et al. (2010). Functional alterations in memory networks in early Alzheimer's disease. Neuromol. Med. 12, 27-43. doi: 10.1007/s12017-009-8109-7
113. Starks, E. J., Patrick O'Grady, J., Hoscheidt, S. M., Racine, A. M., Carlsson, C. M., Zetterberg, H., et al. (2015). Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOEe4 carriers. J. Alzheimers. Dis. 46, 525-533. doi: 10.3233/JAD-150072
114. Steen, E., Terry, B. M., Rivera, E. J., Cannon, J. L., Neely, T. R., Tavares, R., et al. (2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J. Alzheimers Dis. 7, 63-80. doi: 10.3233/JAD-2005-7107
115. Stern, S. A., Chen, D. Y., and Alberini, C. M. (2014). The effect of insulin and insulin-like growth factors on hippocampus-and amygdala-dependent long-term memory formation. Learn. Mem. 21, 556-563. doi: 10.1101/lm.029348.112
116. Stöhr, O., Schilbach, K., Moll, L., Hettich, M. M., Freude, S., Wunderlich, F. T., et al. (2013). Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease. Age 35, 83-101. doi: 10.1007/s11357-011-9333-2
117. Stranahan, A. M., Arumugam, T. V., Cutler, R. G., Lee, K., Egan, J. M., and Mattson, M. P. (2008). Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11, 309-317. doi: 10.1038/nn2055
118. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., et al. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981
119. Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., et al. (2012). Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316-1338. doi: 10.1172/JCI59903
120. Thambisetty, M., Metter, E. J., Yang, A., Dolan, H., Marano, C., Zonderman, A. B., et al. (2013). Glucose intolerance, insulin resistance, and pathological features of alzheimer disease in the baltimore longitudinal study of aging. JAMA Neurol. 70 1167-1172. doi: 10.1001/jamaneurol.2013.284
121. Thienel, M., Wilhelm, I., Benedict, C., Born, J., and Hallschmid, M. (2017). Intranasal insulin decreases circulating cortisol concentrations during early sleep in elderly humans. Neurobiol. Aging 54, 170-174. doi: 10.1016/j.neurobiolaging.2017.03.006
122. van der Harg, J. M., Eggels, L., Bangel, F. N., Ruigrok, S. R., Zwart, R., Hoozemans, J. J. M., et al. (2017). Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation. Neurobiol. Dis. 103, 163-173. doi: 10.1016/j.nbd.2017.04.005
123. Vandal, M., White, P. J., Tremblay, C., St-Amour, I., Chevrier, G., Emond, V., et al. (2014). Insulin reverses the high-fat diet-induced increase in brain a and improves memory in an animal model of Alzheimer disease. Diabetes 63, 4291-4301. doi: 10.2337/db14-0375
124. Velazquez, R., Tran, A., Ishimwe, E., Denner, L., Dave, N., Oddo, S., et al. (2017). Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease. Neurobiol. Aging 58, 1-13. doi: 10.1016/j.neurobiolaging.2017.06.003
125. Wang, X., Zheng, W., Xie, J.-W., Wang, T., Wang, S.-L., Teng, W.-P., et al. (2010). Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol. Neurodegener. 5:46. doi: 10.1186/1750-1326-5-46
126. Wang, Y., and Mandelkow, E. (2016). Tau in physiology and pathology. Nat. Rev. Neurosci. 17, 5-21. doi: 10.1038/nrn.2015.1
127. Watson, J. M., Sherwin, R. S., Deary, I. J., Scott, L., and Kerr, D. (2003). Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Clin. Sci. 104, 447-454. doi: 10.1042/cs1040447
128. Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., et al. (2015). Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement. 11, 504.e1-510.e1. doi: 10.1016/j.jalz.2014.03.011
129. Winocur, G., Greenwood, C. E., Piroli, G. G., Grillo, C., Reznikov, L. R., Reagan, L. P., et al. (2005). Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav. Neurosci. 119, 1389-1395. doi: 10.1037/0735-7044.119.5.1389
130. Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., et al. (1988). Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85, 4506-4510
131. Woods, S. C., Lotter, E. C., McKay, L. D., and Porte, D. (1979). Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503-505
132. Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., et al. (2013). Sleep drives metabolite clearance from the adult brain. Science 342, 373-377. doi: 10.1126/science.1241224
133. Yarchoan, M., and Arnold, S. E. (2014). Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes 63, 2253-2261. doi: 10.2337/db14-0287
134. Yarchoan, M., Toledo, J. B., Lee, E. B., Arvanitakis, Z., Kazi, H., Han, L.-Y., et al. (2014). Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 128, 679-689. doi: 10.1007/s00401-014-1328-5
135. Zhang, H., Hao, Y., Manor, B., Novak, P., Milberg, W., Zhang, J., et al. (2015). Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes 64, 1025-1034. doi: 10.2337/db14-1000
136. Zhang, J., Chen, C., Hua, S., Liao, H., Wang, M., Xiong, Y., et al. (2017). An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer's disease. Diabetes Res. Clin. Pract. 124, 41-47. doi: 10.1016/j.diabres.2016.10.024